In the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
Others have stated their priorities directly with Federal Government. Through these interviews, AHJ gives a final opportunity to communicate to all health stakeholders, the funding needs for a range of priorities. These range from new models of care to pilots and wholesale, system improvements to building more sustainable workforces to help grow certain sectors of the health system
The CEO of Australian Primary Health Care Nurses Association (APNA), Ken Griffin spoke with Australian Health Journal about the following:
- APNA President Karen Booth representing Primary Care Nursing in the Australian Government led Strengthening Medicare Task Force
- The current key challenges in primary care nursing
- Programs on diversity and student placement proposed in APNA’s pre-budget submission to Federal Government
- A proposed initiative called Nurse-Supported Self-Care, with broadening role primary care nursing would play in the community
And lastly Ken talks about primary care nursing able to make an impact in aged care through Government funding, to support a residential aged care workforce that will only come into existence from 1st July 2023. He also talks about nurses needing accommodation assistance when moving to regional and remote locations in Australia.
In closing Ken talks about Government needing to “catchup the care for chronic disease” with support for multiple workforces including allied health and multidisciplinary teams. To alleviate the pressure on hospitals, workforce policies need to be assessed to be able to deliver the necessary assessment and management of chronic disease.
You Might also like
- 
					
					Understanding extracellular vesicles in cancer therapy researchJoy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland. Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics. 
- 
					
					Dental marketing insights from leading authorityWinning the Australian Dental Industry Award for Marketing has had a big impact to Dental Marketing Solutions. As Angus comments in closing, “Receiving the award is social proof to say, well, these guys must know something, because an independent body of their peers has assessed them and said”. He added, “Certainly it’s been good in terms of building our business.” 
- 
					
					Awareness, diagnosis and treatment of Congenital HypothyroidismAustralian Health Journal spoke to Associate Professor MIchelle Jack about congenital hypothyroidism and newborn screening and her concerns in the varying thresholds for across different states in Australia. Despite the existence of newborn screening programs since the 1970s, there is still controversy surrounding the appropriate screening levels. Congenital hypothyroidism, affecting about one in 3500 infants, can lead to severe intellectual and physical impairment if not diagnosed early. The condition is mainly caused by the thyroid gland’s failure to develop properly, resulting in insufficient thyroid hormone production. 
 
		
		 
					
																				
					 
					
																				
					